Report DMCA A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid t
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.